Illustration for: Oura, World Labs Show Two Paths Out For Startups

Oura, World Labs Show Two Paths Out For Startups

Oura's stalled IPO and AMD's smooth $8.2 billion acquisition of World Labs show 2026 rewarding M&A exits over public listings for venture-backed AI companies.

By the Numbers

$8.2B (all-stock)
World Labs deal
$2.2B
Oura IPO target
+68%
Cerebras IPO day-1 pop
TC
By the IPO Desk
Edited by Trace Cohen · Early-stage VC & angel · Founder, New York Venture Partners
2 min read
ShareXLinkedInEmail

THE RUNDOWN

1

AMD's all-stock acquisition of World Labs closed without incident the same week Oura pulled its IPO hours before pricing, the cleanest same-week contrast yet between the two major venture exit paths.

2

M&A avoids the weeks-long public-market exposure window that sank Oura's deal -- a structural advantage during exactly the kind of rate and volatility conditions the market is in right now.

3

AMD paying all-stock rather than cash means World Labs shareholders still carry AMD's stock-price risk -- M&A isn't risk-free, it's differently risky, and faster to close.

4

Cerebras' own IPO debut, up 68% on day one, shows public listings aren't dead when conditions cooperate -- the lesson is M&A's relative advantage is specific to volatile windows, not permanent.

TC

The VC Read · Trace's Take

Trace Cohen

If you're a fund with 2026-vintage DPI riding on an IPO exit, model the M&A path now, not as a fallback but as the base case -- AMD-style all-stock deals are closing in weeks while IPO issuers eat multi-week public exposure to exactly the volatility that just killed Oura's timeline. The number to watch is how many of the companies behind Oura in the IPO queue quietly explore a sale instead of re-filing.

Analysis

The same week Oura postponed its IPO, AMD's $8.2 billion all-stock acquisition of Fei-Fei Li's World Labs closed without incident -- a contrast The Information's Dealmaker newsletter framed bluntly: 2026 is shaping up to be a great year for venture exits, as long as the exit is M&A, not an IPO.

Two Exit Paths, Two Outcomes

Pulse covered AMD's acquisition of World Labs when it was announced -- an all-stock deal that gave World Labs' investors and employees a clean, immediate outcome with no public-market timing risk. Oura's path required marketing a deal to public investors for weeks, only to pull the deal hours before pricing once market conditions turned. Same category -- AI-adjacent, venture-backed, multibillion-dollar -- fundamentally different exposure to market timing.

“Same category -- AI-adjacent, venture-backed, multibillion-dollar -- fundamentally different exposure to market timing.”

Why M&A Is Outperforming IPOs Right Now

An acquirer like AMD prices a deal once, in private negotiation, and both sides can move quickly to close before conditions change. An IPO requires sustained public-market appetite across the entire marketing period -- often several weeks of roadshow -- during which yields can rise, sentiment can sour, and the deal can be pulled at the last minute, exactly as happened to Oura. In a market where bond yields are climbing and AI-stock volatility is elevated, that multi-week exposure window is itself a cost IPO issuers are paying that M&A sellers simply don't face.

The Numbers In Context

AMD paid all-stock for World Labs rather than cash, meaning World Labs shareholders are still exposed to AMD's own stock-price risk rather than a locked-in cash outcome -- not a risk-free exit, just a different and faster one than Oura's stalled $2.2 billion, roughly $15 billion-valuation IPO attempt. For founders and VCs weighing exit paths into 2027, the lesson isn't that IPOs are dead -- as Cerebras' own IPO debut showed, closing +68% on day one -- it's that M&A is proving the more reliable path specifically during periods of macro volatility, while IPOs remain the higher-ceiling option when the tape cooperates.

Every venture fund with a 2026-vintage counting on IPO-driven DPI needs a real answer for what happens if this volatility extends into 2027 -- and M&A, not a public listing, may be the more realistic path for the next wave of AI-adjacent exits behind Oura in the queue.

ShareXLinkedInEmail

Key Sources

2 sources

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.